VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q56154469  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241221010727.0
008     241221nneanz||abbn n and d
035 ‎‡a  (WKP)Q56154469‏
024 ‎‡a  0000-0002-1014-2614‏ ‎‡2  orcid‏
024 ‎‡a  7201360145‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q56154469‏
100 0 ‎‡a  Robin J. Thomson‏ ‎‡9  ast‏ ‎‡9  es‏ ‎‡9  sl‏
400 0 ‎‡a  Robin J. Thomson‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Robin J. Thomson‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's A sialosyl sulfonate as a potent inhibitor of influenza virus replication‏
670 ‎‡a  Author's A Sulfonozanamivir Analogue has Potent Anti-influenza Virus Activity.‏
670 ‎‡a  Author's A unique sialidase that cleaves the Neu5Gcalpha2-->5-O(glycolyl)Neu5Gc linkage: comparison of its specificity with that of three microbial sialidases toward four sialic acid dimers.‏
670 ‎‡a  Author's Access to 3-O-Functionalized N-Acetylneuraminic Acid Scaffolds.‏
670 ‎‡a  Author's Accessing C-1 phosphonylated 2-acylamino uronic acids via 2-nitro-glycals‏
670 ‎‡a  Author's Anti-influenza drugs: the development of sialidase inhibitors.‏
670 ‎‡a  Author's Atypical group 1 neuraminidase pH1N1-N1 bound to a group 1 inhibitor‏
670 ‎‡a  Author's Catalysis by a new sialidase, deaminoneuraminic acid residue-cleaving enzyme (KDNase Sm), initially forms a less stable alpha-anomer of 3-deoxy-D-glycero-D-galacto-nonulosonic acid and is strongly inhibited by the transition state analogue, 2-deoxy-‏
670 ‎‡a  Author's cis-bis‏
670 ‎‡a  Author's cis-bis(pyridine)platinum(II) organoamides with unexpected growth inhibition properties and antitumor activity‏
670 ‎‡a  Author's Complexity in influenza virus targeted drug design: interaction with human sialidases.‏
670 ‎‡a  Author's Cracking the code for H5N1-bird flu and beyond.‏
670 ‎‡a  Author's Diversity and distribution of the Caddisflies (Insecta: Trichoptera) of Ecuador‏
670 ‎‡a  Author's Efficient Blocking of Enterovirus 71 Infection by Heparan Sulfate Analogues Acting as Decoy Receptors‏
670 ‎‡a  Author's Functional and structural characterization of a heparanase‏
670 ‎‡a  Author's Imaging of influenza virus sialidase activity in living cells‏
670 ‎‡a  Author's Modelling, synthesis and biological evaluation of novel glucuronide-based probes of Vibrio cholerae sialidase.‏
670 ‎‡a  Author's New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase‏
670 ‎‡a  Author's Novel 3,4-disubstituted-Neu5Ac2en derivatives as probes to investigate flexibility of the influenza virus sialidase 150-loop.‏
670 ‎‡a  Author's Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase‏
670 ‎‡a  Author's Ralph W. Holzenthal – a mentor and friend retires‏
670 ‎‡a  Author's Rapid access to uronic acid-based mimetics of Kdn2en from D-glucurono-6,3-lactone‏
670 ‎‡a  Author's Saturation transfer difference‏
670 ‎‡a  Author's Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase‏
670 ‎‡a  Author's Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus‏
670 ‎‡a  Author's Structural characterisation of high affinity Siglec-2‏
670 ‎‡a  Author's Structural characterisation of high affinity Siglec-2 (CD22) ligands in complex with whole Burkitt's lymphoma (BL) Daudi cells by NMR spectroscopy‏
670 ‎‡a  Author's Structural insights into human parainfluenza virus type-3 haemagglutinin-neuraminidase using unsaturated 3- N-substituted sialic acids as probes.‏
670 ‎‡a  Author's Synthesis and biological evaluation of galactofuranosyl alkyl thioglycosides as inhibitors of mycobacteria‏
670 ‎‡a  Author's Synthesis and evaluation of galactofuranosyl N,N-dialkyl sulfenamides and sulfonamides as antimycobacterial agents.‏
670 ‎‡a  Author's Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility‏
670 ‎‡a  Author's Unsaturated N-acetyl- D-glucosaminuronic acid glycosides as inhibitors of influenza virus sialidase.‏
670 ‎‡a  Author's Uronosyl phosphonate-based sialidase inhibitor synthesis and conformational analysis.‏
909 ‎‡a  (scopus) 7201360145‏ ‎‡9  1‏
909 ‎‡a  (orcid) 0000000210142614‏ ‎‡9  1‏
919 ‎‡a  antiinfluenzadrugsthedevelopmentofsialidaseinhibitors‏ ‎‡A  Anti-influenza drugs: the development of sialidase inhibitors.‏ ‎‡9  1‏
919 ‎‡a  structuralinsightsintohumanparainfluenzavirustype3haemagglutininneuraminidaseusingunsaturated3nsubstitutedsialicacidsasprobes‏ ‎‡A  Structural insights into human parainfluenza virus type-3 haemagglutinin-neuraminidase using unsaturated 3- N-substituted sialic acids as probes.‏ ‎‡9  1‏
919 ‎‡a  synthesisandbiologicalevaluationofgalactofuranosylalkylthioglycosidesasinhibitorsofmycobacteria‏ ‎‡A  Synthesis and biological evaluation of galactofuranosyl alkyl thioglycosides as inhibitors of mycobacteria‏ ‎‡9  1‏
919 ‎‡a  synthesisandevaluationofgalactofuranosylnndialkylsulfenamidesandsulfonamidesasantimycobacterialagents‏ ‎‡A  Synthesis and evaluation of galactofuranosyl N,N-dialkyl sulfenamides and sulfonamides as antimycobacterial agents.‏ ‎‡9  1‏
919 ‎‡a  synthesisandevaluationofnovel3100alkylatedneu5ac2enderivativesasprobesofinfluenzavirussialidase150loopflexibility‏ ‎‡A  Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility‏ ‎‡9  1‏
919 ‎‡a  unsaturatednacetyl500glucosaminuronicacidglycosidesasinhibitorsofinfluenzavirussialidase‏ ‎‡A  Unsaturated N-acetyl- D-glucosaminuronic acid glycosides as inhibitors of influenza virus sialidase.‏ ‎‡9  1‏
919 ‎‡a  uronosylphosphonatebasedsialidaseinhibitorsynthesisandconformationalanalysis‏ ‎‡A  Uronosyl phosphonate-based sialidase inhibitor synthesis and conformational analysis.‏ ‎‡9  1‏
919 ‎‡a  atypicalgroup1neuraminidaseph1n1n1boundtoagroup1inhibitor‏ ‎‡A  Atypical group 1 neuraminidase pH1N1-N1 bound to a group 1 inhibitor‏ ‎‡9  1‏
919 ‎‡a  catalysisbyanewsialidasedeaminoneuraminicacidresiduecleavingenzymekdnasesminitiallyformsalessstablealphaanomerof3deoxy500glycero500galactononulosonicacidandisstronglyinhibitedbythetransitionstateanalogue2deoxy‏ ‎‡A  Catalysis by a new sialidase, deaminoneuraminic acid residue-cleaving enzyme (KDNase Sm), initially forms a less stable alpha-anomer of 3-deoxy-D-glycero-D-galacto-nonulosonic acid and is strongly inhibited by the transition state analogue, 2-deoxy-‏ ‎‡9  1‏
919 ‎‡a  cisbis‏ ‎‡A  cis-bis‏ ‎‡9  1‏
919 ‎‡a  structuralcharacterisationofhighaffinitysiglec2cd22ligandsincomplexwithwholeburkittslymphomabldaudicellsbynmrspectroscopy‏ ‎‡A  Structural characterisation of high affinity Siglec-2 (CD22) ligands in complex with whole Burkitt's lymphoma (BL) Daudi cells by NMR spectroscopy‏ ‎‡9  1‏
919 ‎‡a  sialosylsulfonateasapotentinhibitorofinfluenzavirusreplication‏ ‎‡A  A sialosyl sulfonate as a potent inhibitor of influenza virus replication‏ ‎‡9  1‏
919 ‎‡a  structuralcharacterisationofhighaffinitysiglec2‏ ‎‡A  Structural characterisation of high affinity Siglec-2‏ ‎‡9  1‏
919 ‎‡a  cisbispyridineplatinum2organoamideswithunexpectedgrowthinhibitionpropertiesandantitumoractivity‏ ‎‡A  cis-bis(pyridine)platinum(II) organoamides with unexpected growth inhibition properties and antitumor activity‏ ‎‡9  1‏
919 ‎‡a  structuralanalysisofadesignedinhibitorcomplexedwiththehemagglutininneuraminidaseofnewcastlediseasevirus‏ ‎‡A  Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus‏ ‎‡9  1‏
919 ‎‡a  complexityininfluenzavirustargeteddrugdesigninteractionwithhumansialidases‏ ‎‡A  Complexity in influenza virus targeted drug design: interaction with human sialidases.‏ ‎‡9  1‏
919 ‎‡a  crackingthecodeforh5n1birdfluandbeyond‏ ‎‡A  Cracking the code for H5N1-bird flu and beyond.‏ ‎‡9  1‏
919 ‎‡a  diversityanddistributionofthecaddisfliesinsectatrichopteraofecuador‏ ‎‡A  Diversity and distribution of the Caddisflies (Insecta: Trichoptera) of Ecuador‏ ‎‡9  1‏
919 ‎‡a  efficientblockingofenterovirus71infectionbyheparansulfateanaloguesactingasdecoyreceptors‏ ‎‡A  Efficient Blocking of Enterovirus 71 Infection by Heparan Sulfate Analogues Acting as Decoy Receptors‏ ‎‡9  1‏
919 ‎‡a  functionalandstructuralcharacterizationofaheparanase‏ ‎‡A  Functional and structural characterization of a heparanase‏ ‎‡9  1‏
919 ‎‡a  imagingofinfluenzavirussialidaseactivityinlivingcells‏ ‎‡A  Imaging of influenza virus sialidase activity in living cells‏ ‎‡9  1‏
919 ‎‡a  modellingsynthesisandbiologicalevaluationofnovelglucuronidebasedprobesofvibriocholeraesialidase‏ ‎‡A  Modelling, synthesis and biological evaluation of novel glucuronide-based probes of Vibrio cholerae sialidase.‏ ‎‡9  1‏
919 ‎‡a  newantiviralapproachesforhumanparainfluenzainhibitingthehaemagglutininneuraminidase‏ ‎‡A  New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase‏ ‎‡9  1‏
919 ‎‡a  novel34disubstitutedneu5ac2enderivativesasprobestoinvestigateflexibilityoftheinfluenzavirussialidase150loop‏ ‎‡A  Novel 3,4-disubstituted-Neu5Ac2en derivatives as probes to investigate flexibility of the influenza virus sialidase 150-loop.‏ ‎‡9  1‏
919 ‎‡a  novelsialicacidderivativeslockopenthe150loopofaninfluenzaavirusgroup1sialidase‏ ‎‡A  Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase‏ ‎‡9  1‏
919 ‎‡a  ralphwholzenthalamentorandfriendretires‏ ‎‡A  Ralph W. Holzenthal – a mentor and friend retires‏ ‎‡9  1‏
919 ‎‡a  rapidaccesstouronicacidbasedmimeticsofkdn2enfrom500glucurono63lactone‏ ‎‡A  Rapid access to uronic acid-based mimetics of Kdn2en from D-glucurono-6,3-lactone‏ ‎‡9  1‏
919 ‎‡a  saturationtransferdifference‏ ‎‡A  Saturation transfer difference‏ ‎‡9  1‏
919 ‎‡a  saturationtransferdifferencestd1hnmrexperimentsandinsilicodockingexperimentstoprobethebindingofnacetylneuraminicacidandderivativestovibriocholeraesialidase‏ ‎‡A  Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase‏ ‎‡9  1‏
919 ‎‡a  sulfonozanamiviranaloguehaspotentantiinfluenzavirusactivity‏ ‎‡A  A Sulfonozanamivir Analogue has Potent Anti-influenza Virus Activity.‏ ‎‡9  1‏
919 ‎‡a  uniquesialidasethatcleavestheneu5gcalpha25oglycolylneu5gclinkagecomparisonofitsspecificitywiththatof3microbialsialidasestoward4sialicaciddimers‏ ‎‡A  A unique sialidase that cleaves the Neu5Gcalpha2-->5-O(glycolyl)Neu5Gc linkage: comparison of its specificity with that of three microbial sialidases toward four sialic acid dimers.‏ ‎‡9  1‏
919 ‎‡a  accessto3ofunctionalizednacetylneuraminicacidscaffolds‏ ‎‡A  Access to 3-O-Functionalized N-Acetylneuraminic Acid Scaffolds.‏ ‎‡9  1‏
919 ‎‡a  accessing1001phosphonylated2acylaminouronicacidsvia2nitroglycals‏ ‎‡A  Accessing C-1 phosphonylated 2-acylamino uronic acids via 2-nitro-glycals‏ ‎‡9  1‏
996 ‎‡2  LC|n 88020103‏
996 ‎‡2  ISNI|0000000362586281‏
996 ‎‡2  LC|no2020114923‏
996 ‎‡2  J9U|987007367102705171‏
996 ‎‡2  ISNI|000000004162614X‏
996 ‎‡2  BNF|12136393‏
996 ‎‡2  NKC|jo20241213018‏
996 ‎‡2  LC|n 50012264‏
996 ‎‡2  BNF|12380215‏
996 ‎‡2  ISNI|0000000084034793‏
996 ‎‡2  ISNI|0000000027523881‏
996 ‎‡2  LC|n 85336559‏
996 ‎‡2  DNB|1341419452‏
996 ‎‡2  CAOONL|ncf11707770‏
996 ‎‡2  BIBSYS|90847655‏
996 ‎‡2  DNB|1052346715‏
996 ‎‡2  ISNI|0000000423048728‏
996 ‎‡2  DNB|1157716121‏
996 ‎‡2  J9U|987007439120705171‏
996 ‎‡2  LIH|LNB:B,F_q_;=B_a_‏
996 ‎‡2  DNB|142241229‏
996 ‎‡2  J9U|987007278742105171‏
996 ‎‡2  NUKAT|n 2009703016‏
996 ‎‡2  RERO|A003898756‏
996 ‎‡2  NTA|068460554‏
996 ‎‡2  LC|no2002034762‏
996 ‎‡2  NTA|104723300‏
996 ‎‡2  BIBSYS|90746470‏
996 ‎‡2  BAV|495_295948‏
996 ‎‡2  ISNI|0000000075523616‏
996 ‎‡2  NUKAT|n 2016200834‏
996 ‎‡2  SUDOC|033160996‏
996 ‎‡2  LC|no 97028742‏
996 ‎‡2  CAOONL|ncf11159240‏
996 ‎‡2  NSK|000750247‏
996 ‎‡2  ISNI|0000000454979699‏
996 ‎‡2  SUDOC|029817706‏
996 ‎‡2  ISNI|0000000074061499‏
996 ‎‡2  N6I|vtls000347142‏
996 ‎‡2  NKC|mub2010611895‏
996 ‎‡2  LC|nr 93039541‏
996 ‎‡2  BIBSYS|1579001847797‏
996 ‎‡2  CAOONL|ncf10152258‏
996 ‎‡2  LC|no 89014604‏
996 ‎‡2  BIBSYS|6092728‏
996 ‎‡2  NTA|070788340‏
996 ‎‡2  NYNYRILM|187888‏
996 ‎‡2  ISNI|0000000382616644‏
996 ‎‡2  BNCHL|10000000000000000018925‏
996 ‎‡2  SZ|1044472286‏
996 ‎‡2  ISNI|0000000448827867‏
996 ‎‡2  NII|DA01365311‏
996 ‎‡2  RERO|A022857538‏
996 ‎‡2  CAOONL|ncf10387330‏
996 ‎‡2  ISNI|0000000433877896‏
996 ‎‡2  CAOONL|ncf10212621‏
996 ‎‡2  ISNI|0000000052450434‏
996 ‎‡2  NLA|000068358506‏
996 ‎‡2  ISNI|0000000078949428‏
996 ‎‡2  ISNI|0000000393404225‏
996 ‎‡2  CAOONL|ncf10138363‏
996 ‎‡2  LC|no2015163323‏
996 ‎‡2  LNB|LNC10-000188359‏
996 ‎‡2  J9U|987007425550405171‏
996 ‎‡2  J9U|987007268972305171‏
996 ‎‡2  ISNI|0000000063199513‏
996 ‎‡2  RERO|A024819545‏
996 ‎‡2  LC|no2021082934‏
996 ‎‡2  ISNI|0000000084657456‏
996 ‎‡2  NTA|182323447‏
996 ‎‡2  LC|n 2016019242‏
996 ‎‡2  PLWABN|9812829505105606‏
996 ‎‡2  ISNI|0000000027495307‏
996 ‎‡2  DNB|117625825‏
996 ‎‡2  ISNI|0000000021512081‏
996 ‎‡2  J9U|987007286699605171‏
996 ‎‡2  ISNI|0000000114729423‏
996 ‎‡2  CAOONL|ncf11204904‏
996 ‎‡2  SUDOC|240980913‏
996 ‎‡2  CAOONL|ncf10135984‏
996 ‎‡2  ISNI|000000002790721X‏
996 ‎‡2  CAOONL|ncf10355151‏
996 ‎‡2  LC|n 78030638‏
996 ‎‡2  CAOONL|ncf10634945‏
996 ‎‡2  ISNI|000000044940062X‏
996 ‎‡2  LC|n 89102345‏
996 ‎‡2  SUDOC|129638897‏
996 ‎‡2  ISNI|0000000069175774‏
996 ‎‡2  LC|no2016023492‏
996 ‎‡2  SUDOC|238097846‏
996 ‎‡2  LC|no2012030953‏
996 ‎‡2  BNC|981060990164406706‏
996 ‎‡2  DNB|1237111080‏
996 ‎‡2  ISNI|0000000451419645‏
996 ‎‡2  ISNI|0000000109559554‏
996 ‎‡2  LC|nb 97075819‏
996 ‎‡2  CAOONL|ncf10186652‏
996 ‎‡2  LC|nr 93039531‏
996 ‎‡2  LC|n 78000157‏
996 ‎‡2  DNB|1228572828‏
996 ‎‡2  ISNI|000000005501120X‏
996 ‎‡2  PLWABN|9810582397205606‏
996 ‎‡2  BNF|12405583‏
996 ‎‡2  PLWABN|9810677177105606‏
996 ‎‡2  DNB|1146489633‏
996 ‎‡2  ISNI|0000000079018414‏
996 ‎‡2  LC|n 82029285‏
996 ‎‡2  BIBSYS|90236926‏
996 ‎‡2  NUKAT|n 2019008820‏
996 ‎‡2  NUKAT|n 00066305‏
996 ‎‡2  NLA|000035825723‏
996 ‎‡2  NLA|000035037204‏
996 ‎‡2  ISNI|0000000367637033‏
996 ‎‡2  N6I|vtls001262833‏
996 ‎‡2  NTA|227461126‏
996 ‎‡2  N6I|vtls000017333‏
996 ‎‡2  J9U|987007271744705171‏
996 ‎‡2  BIBSYS|15018642‏
996 ‎‡2  LC|n 85109358‏
996 ‎‡2  LC|n 82034860‏
996 ‎‡2  ISNI|0000000123953451‏
996 ‎‡2  SUDOC|259102725‏
996 ‎‡2  BIBSYS|4074396‏
996 ‎‡2  SUDOC|198073704‏
996 ‎‡2  SUDOC|185548814‏
996 ‎‡2  CAOONL|ncf10315794‏
996 ‎‡2  LC|n 82038305‏
996 ‎‡2  LC|no2020140408‏
996 ‎‡2  NII|DA15574998‏
996 ‎‡2  SUDOC|174327447‏
996 ‎‡2  ISNI|0000000108558584‏
996 ‎‡2  NUKAT|n 2003081473‏
996 ‎‡2  DNB|116382187X‏
996 ‎‡2  LC|n 92016742‏
996 ‎‡2  NUKAT|n 2011204017‏
996 ‎‡2  SUDOC|254814905‏
996 ‎‡2  BNF|12020811‏
996 ‎‡2  NII|DA02395384‏
996 ‎‡2  LC|n 2006054986‏
996 ‎‡2  RERO|A003898755‏
996 ‎‡2  J9U|987007283328805171‏
996 ‎‡2  SUDOC|103922326‏
996 ‎‡2  BIBSYS|10024015‏
996 ‎‡2  LC|no2005043905‏
996 ‎‡2  J9U|987007334563705171‏
996 ‎‡2  BNF|14233029‏
996 ‎‡2  NKC|jx20071010014‏
996 ‎‡2  DNB|117625841‏
996 ‎‡2  DNB|174117590‏
996 ‎‡2  ISNI|0000000501232206‏
996 ‎‡2  NSK|000623261‏
996 ‎‡2  DNB|1044472286‏
996 ‎‡2  NII|DA03963766‏
996 ‎‡2  LC|n 00026046‏
996 ‎‡2  NSK|000364130‏
996 ‎‡2  LC|nr 96024152‏
996 ‎‡2  CAOONL|ncf11427766‏
996 ‎‡2  LIH|LNB:B_n_N_p_;=B__‏
996 ‎‡2  LC|no 95035988‏
996 ‎‡2  LC|no2020016401‏
996 ‎‡2  ISNI|000000007254020X‏
996 ‎‡2  NTA|068064535‏
996 ‎‡2  RERO|A022804504‏
996 ‎‡2  NLA|000065341073‏
996 ‎‡2  LC|n 88081671‏
996 ‎‡2  ISNI|0000000439837924‏
996 ‎‡2  NUKAT|n 2003049094‏
996 ‎‡2  PLWABN|9810640243305606‏
996 ‎‡2  ISNI|0000000039727937‏
996 ‎‡2  CAOONL|ncf11369509‏
996 ‎‡2  RERO|A023991883‏
996 ‎‡2  NII|DA04069472‏
996 ‎‡2  NTA|159028736‏
996 ‎‡2  ISNI|0000000023642744‏
996 ‎‡2  RERO|A008851395‏
996 ‎‡2  NTA|073930814‏
996 ‎‡2  BIBSYS|90288499‏
996 ‎‡2  NUKAT|n 01714702‏
996 ‎‡2  ISNI|0000000114614802‏
996 ‎‡2  DNB|1153903911‏
996 ‎‡2  LC|n 87881016‏
996 ‎‡2  SZ|1153903911‏
996 ‎‡2  DNB|1052005373‏
996 ‎‡2  ISNI|0000000028526611‏
996 ‎‡2  DNB|1027032265‏
996 ‎‡2  ISNI|0000000074716344‏
996 ‎‡2  SUDOC|255095449‏
996 ‎‡2  RERO|A012010666‏
996 ‎‡2  J9U|987007358155405171‏
996 ‎‡2  DNB|11735192X‏
996 ‎‡2  NII|DA02947684‏
996 ‎‡2  DNB|1265792305‏
996 ‎‡2  NKC|skuk0005601‏
996 ‎‡2  LC|no 90014736‏
996 ‎‡2  BIBSYS|97049339‏
996 ‎‡2  LC|no2019119908‏
996 ‎‡2  LC|n 00067646‏
996 ‎‡2  NUKAT|n 00022517‏
996 ‎‡2  LC|n 81088241‏
996 ‎‡2  NTA|424194007‏
996 ‎‡2  ISNI|0000000075534278‏
996 ‎‡2  NUKAT|n 2012043682‏
996 ‎‡2  NKC|xx0258774‏
996 ‎‡2  CAOONL|ncf10317231‏
996 ‎‡2  NTA|409021474‏
996 ‎‡2  CAOONL|ncf11919888‏
996 ‎‡2  BIBSYS|90709752‏
996 ‎‡2  SUDOC|229585957‏
996 ‎‡2  LC|no 95011085‏
996 ‎‡2  LC|n 2018066479‏
996 ‎‡2  SUDOC|151507619‏
996 ‎‡2  N6I|vtls000080314‏
996 ‎‡2  ISNI|0000000116672539‏
996 ‎‡2  NLA|000035548658‏
996 ‎‡2  LC|n 94111460‏
996 ‎‡2  NDL|00458700‏
996 ‎‡2  LC|no2010157909‏
996 ‎‡2  NTA|255738552‏
996 ‎‡2  J9U|987007268972205171‏
996 ‎‡2  LC|nr 97023321‏
996 ‎‡2  LC|n 85388055‏
996 ‎‡2  SUDOC|087937328‏
996 ‎‡2  ISNI|0000000395674835‏
996 ‎‡2  DNB|1061388190‏
996 ‎‡2  SUDOC|028355814‏
996 ‎‡2  LC|no2023069029‏
996 ‎‡2  DNB|135659175‏
996 ‎‡2  DNB|1121597467‏
996 ‎‡2  NTA|069518319‏
996 ‎‡2  NKC|jo2013797153‏
996 ‎‡2  LC|n 84051950‏
996 ‎‡2  ISNI|0000000073917638‏
996 ‎‡2  SELIBR|254813‏
996 ‎‡2  SUDOC|232804575‏
996 ‎‡2  NII|DA18666061‏
996 ‎‡2  LIH|LNB:BF_r__m_;=B3‏
996 ‎‡2  LC|nb2002038355‏
996 ‎‡2  PLWABN|9813201510605606‏
996 ‎‡2  ISNI|0000000395832039‏
996 ‎‡2  CAOONL|ncf11164690‏
996 ‎‡2  CAOONL|ncf12083295‏
996 ‎‡2  LC|n 81129415‏
996 ‎‡2  LC|n 87882385‏
996 ‎‡2  SUDOC|150546556‏
996 ‎‡2  LC|n 86821681‏
996 ‎‡2  SUDOC|098888188‏
996 ‎‡2  BIBSYS|90101743‏
996 ‎‡2  BIBSYS|90233810‏
996 ‎‡2  NUKAT|n 2016150882‏
996 ‎‡2  LC|no2014060177‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏